The "Stabilized Urea Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ...

This study delivers an in-depth evaluation across technology categories (water-soluble fertilizers, controlled-release fertilizers, slow-release fertilizers, micronutrients, liquid formulations), ...

The first experiment was conducted in a greenhouse using a completely randomized design with five treatments and four replications. Treatments consisted of a control (without N application), urea (Ur) ...

The global N-(n-propyl) thiophosphoric triamide (NPPT) urease inhibitor market is experiencing rapid expansion as agricultural producers seek to improve nitrogen use efficiency, reduce ...

The Food and Drug Administration on Thursday approved a new cholesterol pill from Merck that works in a different way from statins. The daily pill, called Lipfendra, is known as a PCSK9 inhibitor — a ...

Trials of current B cell-directed therapies and an investigational inhibitor of the alternative complement pathway demonstrate proteinuria reduction in patients with IgA nephropathy. Targeting ...

Trutakna (atacicept-vymj), a first-in-class dual BAFF and APRIL inhibitor, secured FDA accelerated approval to reduce proteinuria in adults with primary IgA nephropathy, supported by data ...

What Is Skyrizi, and Why Does It Matter? Skyrizi (risankizumab-rzaa) is a prescription biologic used to treat certain immune-mediated inflammatory conditions. It is now approved by the FDA for ...

For patients with advanced solid tumors harboring specific genetic alterations, the first-in-class synthetic lethal combination of WEE1 inhibitor zedoresertib plus PKMYT1 inhibitor lunresertib ...

What Is It, and Why Does It Matter? Icotyde (icotrokinra) is a once-daily pill for moderate to severe plaque psoriasis. It is for adults and for those 12 years and older who weigh at least 40 ...